References
- Benedict W F, Baker M S, Haroun L, et al. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test. Cancer Res 1977; 37: 2209–2213
- Sieber S M, Adamson R H (1975) The clastogenic, mutagenic, teratogenic and carcinogenic effects of various antineoplastic agents. Pharmacological Basis of Cancer Chemotherapy: 27th Annual Symposium on Fundamental Cancer Research. 1974. Williams and Wilkins, Baltimore, 401–468
- Sieber S M, Adamson R H. Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations, and carcinogenic potential. Advances in Cancer Research, G Klein, S Weinhouse. Academic Press, London 1975; Vol 22: 57–155
- Harris C C. The carcinogenicity of antitumor drugs: A hazard in man. Cancer 1976; 37: 1014–1023
- Ames B N, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 1975; 31: 347–364
- Falck K, Cröhn P, Sorsa M, et al. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1979; 1: 1250–1251
- Nguyen T V, Theiss J C, Matney T S. Exposure of pharmacy personnel to mutagenic antineoplastic drugs. Cancer Res 1982; 42: 4792–4796
- Wolff S. Sister chromatid exchange: The most sensitive mammalian system for determining the effects of mutagenic carcinogens. Genetic Damage in Man Caused by Environmental Agents, K Berg. Academic Press, New York 1979; 229–246
- Abe S, Sasaki M. SCE as an index of mutagenesis and/or carcinogenesis. Sister Chromatid Exchange, A Sandberg. Alan R. Liss, Inc., New York 1982; 461–514
- Raposa T. SCE and chemotherapy of non-cancerous and cancerous conditions. Sister Chromatid Exchange, A Sandberg. Alan R. Liss, Inc., New York 1982; 579–617
- Norppa H, Sorsa M, Vainio H, et al. Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health 1980; 6: 299–301
- Waksvik H, Klepp O, Brogger A. Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep 1981; 65: 607–610
- Stiller A, Obe G, Boll I, et al. No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs. Analyses with peripheral blood and urine of hospital personnel. Mutat Res 1983; 121: 253–259
- Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 1974; 251: 156–158
- Carrano A V, Moore D H, II. The rationale and methodology for quantifying sister chromatid exchange in humans. Mutagenicity: New Horizons in Genetic Toxicology, J A Heddle. Academic Press, New York 1982; 267–304